Late-onset facial abscess formation after cosmetic soft tissue augmentation with bio-alcamid

Oren Goldan, Ioannis Georgiou, Nimrod Farber, Eyal Winkler, Josef Haik, Arie Orenstein

Research output: Contribution to journalArticlepeer-review

Abstract

Bio-Alcamid (BA) (polyalkylimide) was introduced in Europe in 2001. It is a nonresorbable injectable filler for soft tissue augmentation, indicated for a wide variety of clinical applications in reconstructive and cosmetic surgery in conditions where subcutaneous volumetric compensation is required. Although BA biocompatibility was approved by a European Union Certificate (CE), the substance is not a natural component of biologic tissues, and thus inflammation and infection are still potential risks. The authors present a case of BA infection after minor trauma 3 years after bilateral injections to the malar regions in a 43-year-old woman, causing an abscess that required surgical drainage and parenteral antibiotics.

Original languageEnglish
Pages (from-to)416-418
Number of pages3
JournalAesthetic Surgery Journal
Volume27
Issue number4
DOIs
StatePublished - Jul 2007

Fingerprint

Dive into the research topics of 'Late-onset facial abscess formation after cosmetic soft tissue augmentation with bio-alcamid'. Together they form a unique fingerprint.

Cite this